Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Auteurs » - entrée « Masataka Kuwana »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Masataka Komagamine < Masataka Kuwana < Masataka Masuda  Facettes :

List of bibliographic references indexed by Masataka Kuwana

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000F93 (2019) Yoshihito Shima [Japon] ; Yasushi Kawaguchi [Japon] ; Masataka Kuwana [Japon]Add-on tocilizumab versus conventional treatment for systemic sclerosis, and cytokine analysis to identify an endotype to tocilizumab therapy.
001668 (2017) Dinesh Khanna [États-Unis] ; Daniel E. Furst [États-Unis] ; Philip J. Clements [États-Unis] ; Yannick Allanore [France] ; Murray Baron [Canada] ; Lazlo Czirjak [Hongrie] ; Oliver Distler [Suisse] ; Ivan Foeldvari [Allemagne] ; Masataka Kuwana [Japon] ; Marco Matucci-Cerinic [Italie] ; Maureen Mayes [États-Unis] ; Thomas Medsger [États-Unis] ; Peter A. Merkel [États-Unis] ; Janet E. Pope [Canada] ; James R. Seibold [États-Unis] ; Virginia Steen [États-Unis] ; Wendy Stevens [Australie] ; Christopher P. Denton [Royaume-Uni]Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis
001E55 (2015) Keisuke Izumi [Japon] ; Harumi Kuda [Japon] ; Mari Ushikubo [Japon] ; Masataka Kuwana [Japon] ; Tsutomu Takeuchi [Japon] ; Hisaji Oshima [Japon]Tocilizumab is effective against polymyalgia rheumatica: experience in 13 intractable cases.
001E56 (2015) Keisuke Izumi [Japon] ; Yuko Kaneko ; Hidekata Yasuoka ; Noriyuki Seta ; Hideto Kameda ; Masataka Kuwana ; Tsutomu TakeuchiTocilizumab is clinically, functionally, and radiographically effective and safe either with or without low-dose methotrexate in active rheumatoid arthritis patients with inadequate responses to DMARDs and/or TNF inhibitors: a single-center retrospective cohort study (KEIO-TCZ study) at week 52.
002C18 (2013) Naoshi Nishina [Japon] ; Yuko Kaneko [Japon] ; Hideto Kameda [Japon] ; Masataka Kuwana [Japon] ; Tsutomu Takeuchi [Japon]Reduction of plasma IL-6 but not TNF-α by methotrexate in patients with early rheumatoid arthritis: a potential biomarker for radiographic progression
003C50 (2010) Yoshiaki Furuya [Japon] ; Toru Satoh ; Masataka KuwanaInterleukin-6 as a potential therapeutic target for pulmonary arterial hypertension.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Masataka Kuwana" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Masataka Kuwana" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Masataka Kuwana
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021